Needle-Free Vaccines on the Horizon

Although these three alternatives to injections don't look alike, the mechanisms by which they protect against diseases have much in common.

Written byPaul Smaglik
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

See the detailed stories on these vaccines:
Mucosal Tissues Offer Tempting Targets,
Success of Edible Vaccine May Depend on Picking Right Fruit, and
Transcutaneous Methods Get Under the Skin

All trigger disease resistance in systems other than the blood. And examples of all approaches use cholera toxin to fortify that resistance. Genetically engineered fruits and vegetables use it to gird the gut against pathogens. Some nasal methods employ it to marshal sinus lining strength against infectious diseases. And some transdermal strategies apply it to steel the skin's immune responses against childhood ailments.

Some needle-free vaccines utilize multiple approaches. For example, Aviron Inc.'s nasal flu spray triggers a strong response in the mucosal linings of the respiratory system, but it also causes a weak blood serum response and a limited cytotoxic T cell response against invaders.

Stanley Leary/Georgia Technology Research Corporation UNDER THE SKIN: One tiny patch contains 400 needles in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies